These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38897861)

  • 21. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.
    Uhlving HH; Andersen CB; Christensen IJ; Gormsen M; Pedersen KD; Buchvald F; Heilmann C; Nielsen KG; Mortensen J; Moser C; Sengeløv H; Müller KG
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):531-8. PubMed ID: 25498923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between FEV
    Kemp R; Pustulka I; Boerner G; Smela B; Hofstetter E; Sabeva Y; François C
    Respir Med; 2021 Nov; 188():106608. PubMed ID: 34517199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of lung function changes with outcomes in children with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Jung S; Yoon HM; Yoon J; Park M; Rhee ES; Kim H; Koh KN; Lee JS; Im HJ; Yu J
    Pediatr Pulmonol; 2021 Oct; 56(10):3332-3341. PubMed ID: 34357700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Gazourian L; Rogers AJ; Ibanga R; Weinhouse GL; Pinto-Plata V; Ritz J; Soiffer RJ; Antin JH; Washko GR; Baron RM; Ho VT
    Am J Hematol; 2014 Apr; 89(4):404-9. PubMed ID: 24375545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Huang QS; Han TX; Chen Q; Wu J; Zhao P; Wu YJ; He Y; Zhu XL; Fu HX; Wang FR; Zhang YY; Mo XD; Han W; Yan CH; Wang JZ; Chen H; Chen YH; Han TT; Lv M; Chen Y; Wang Y; Xu LP; Liu KY; Huang XJ; Zhang XH
    Bone Marrow Transplant; 2024 Feb; 59(2):239-246. PubMed ID: 38012449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation.
    Barisione G; Bacigalupo A; Crimi E; Brusasco V
    Chest; 2011 Mar; 139(3):633-639. PubMed ID: 20724742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
    Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
    Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
    Gazourian L; Coronata AM; Rogers AJ; Weinhouse GL; Soiffer RJ; Antin JH; Ritz J; Ho VT; Baron RM; Washko GR
    Respir Med; 2013 Feb; 107(2):276-83. PubMed ID: 23195332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of Screening Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in Children After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yoon JS; Chun YH; Lee JW; Chung NG; Cho B
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):e462-7. PubMed ID: 26334431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What are the best pulmonary function test parameters for early detection of post-lung transplant bronchiolitis obliterans syndrome in children?
    Sritippayawan S; Keens TG; Horn MV; Starnes VA; Woo MS
    Pediatr Transplant; 2003 Jun; 7(3):200-3. PubMed ID: 12756044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Yadav H; Peters SG; Keogh KA; Hogan WJ; Erwin PJ; West CP; Kennedy CC
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2264-2269. PubMed ID: 27575542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
    Chien JW; Duncan S; Williams KM; Pavletic SZ
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S106-14. PubMed ID: 19896545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung transplantation for bronchiolitis obliterans syndrome after allogenic hematopoietic stem cell transplantation.
    Gao F; Chen J; Wei D; Wu B; Zhou M
    Front Med; 2018 Apr; 12(2):224-228. PubMed ID: 28752350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical analysis of bronchiolitis obliterans syndrome after haplo- hematopoietic stem cell transplantation].
    Zhuang J; Gu B; Ke P; Liu YJ; Wu XJ; Xue SL; Hu XH; He XF; Ma X; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):404-410. PubMed ID: 31207706
    [No Abstract]   [Full Text] [Related]  

  • 35. Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.
    Bacigalupo A; Chien J; Barisione G; Pavletic S
    Semin Hematol; 2012 Jan; 49(1):15-24. PubMed ID: 22221781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation.
    Sheshadri A; Sacks NC; Healey BE; Raza S; Boerner G; Huang HJ
    Clin Ther; 2022 May; 44(5):755-765.e6. PubMed ID: 35513911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.
    Yoshihara S; Yanik G; Cooke KR; Mineishi S
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):749-59. PubMed ID: 17580252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Gunn ML; Godwin JD; Kanne JP; Flowers ME; Chien JW
    J Thorac Imaging; 2008 Nov; 23(4):244-50. PubMed ID: 19204468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study.
    Chen S; Zhao K; Lin R; Wang S; Fan Z; Huang F; Chen X; Nie D; Du X; Guo Z; Lin D; Xuan L; Xu N; Sun J; Peng Xiang A; Liu Q
    EBioMedicine; 2019 Nov; 49():213-222. PubMed ID: 31668569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
    Williams KM; Pavletic SZ; Lee SJ; Martin PJ; Farthing DE; Hakim FT; Rose J; Manning-Geist BL; Gea-Banacloche JC; Comis LE; Cowen EW; Justus DG; Baird K; Cheng GS; Avila D; Steinberg SM; Mitchell SA; Gress RE
    Transplant Cell Ther; 2022 May; 28(5):264.e1-264.e9. PubMed ID: 35114411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.